Australia is welcome innovative treatment for obesity: Retatrutide. The dual molecule – targeting on both GLP-1 and GIP receptors – shows promising efficacy in global studies, pointing to substantial reductions in body fat. While regulatory clearance remains with the Therapeutic Goods Administrat